# Unither Pharmaceuticals expands Amiens site for Euroject production

Unither Pharmaceuticals is expanding its Amiens site with a production unit dedicated to Euroject and injectable vaccines, aiming for over one billion doses per year with five filling lines.

- Type: Expansion
- Announced: 2025-02-25
- Where: Amiens, France
- Status: announced
- Capacity: over one billion doses per year
- Products: injectable drugs, vaccines
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Unither Pharmaceuticals](https://endata.com/companies/81145.md)

## Sources

- [needleconcept.fr](https://www.needleconcept.fr/unither-pharmaceuticals-and-needle-concepthave-announced-a-strategic-partnership-to-develop-a-new-generation-of-needles-compatible-with-the-euroject-system), 2025-02-25: "Unither Pharmaceuticals is increasing its industrial capacity by expanding its Amiens site to include a production unit specifically dedicated to Euroject® and injectable vaccines."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.